stockrowQIAGEN N.V.
QGEN Healthcare Diagnostics & Research
QIAGEN N.V.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 5.65% from fiscal 2024.
- Revenue
- +0.28%
- EPS
- +7.94%
- Free cash flow
- +30.5%
- Total debt
- +13.8%
Quarter to June 2026, against a year earlier
Follow QGEN
Alert me
QIAGEN N.V. (QGEN) Return on invested capital
QIAGEN N.V.'s return on invested capital over the twelve months to 30 June 2026 was 6.62%, down 0.1 percentage points from fiscal 2025 (6.72%). Over the past ten years it has ranged from −0.48% (fiscal 2019) to 9.91% (fiscal 2021); the current reading is higher than 82% of that period. That is above the Diagnostics & Research industry median of 0.00% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 6.72% | 5.12 |
| FY2024 | 1.60% | (4.41) |
| FY2023 | 6.01% | (2.49) |
| FY2022 | 8.50% | (1.41) |
| FY2021 | 9.91% | 3.88 |
| FY2020 | 6.03% | 6.51 |
| FY2019 | −0.48% | (5.51) |
| FY2018 | 5.03% | 2.11 |
| FY2017 | 2.92% | 0.96 |
| FY2016 | 1.96% | (1.55) |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| QGEN QIAGEN N.V. | 6.62% |
| ICLR ICON PLC compare | 3.84% |
| RVTY Revvity Inc. compare | 2.50% |
| RDNT RadNet, Inc. compare | 2.24% |
| CRL Charles River Laboratories International, Inc. compare | 1.81% |
| MEDP Medpace Holdings, Inc. compare | 0.00% |
| BLLN BillionToOne, Inc. compare | 0.00% |
| GRAL GRAIL, Inc. compare | −14.7% |
| GH Guardant Health, Inc. compare | −25.7% |
| Diagnostics & Research industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on QGEN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement